Navigation Links
China Cord Blood Corporation Files Its Annual Report on Form 20-F/A
Date:10/20/2010

China Cord Blood Corporation Files Its Annual Report on Form 20-F/A -- HONG KONG, Oct. 20 /PRNewswire-Asia-FirstCall/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Accounting News & Issues Click to view news release full screen  

China Cord Blood Corporation Files Its Annual Report on Form 20-F/A

 

HONG KONG, Oct. 20 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation ("CCBC" or "the Company") (NYSE: CO), the first and largest cord blood bank operator in China, today announced that the Company has filed an amendment to its Annual Report on Form 20-F/A, which included audited financial statements for the fiscal year ended March 31, 2010 with the U.S. Securities and Exchange Commission. The Form 20-F/A can be accessed by visiting the U.S. Securities and Exchange Commission's website at www.sec.gov and can also be found at CCBC's website at http://www.chinacordbloodcorp.com , under Investor Relations. CCBC will provide a hard copy of the Annual Report, including a complete set of audited financial statements, free of charge to any shareholder upon request.

About China Cord Blood Corporation

China Cord Blood Corporation is the first and largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood bank operator with multiple licenses. Under the current PRC government regulations, only one licensed cord blood bank operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today. China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services. For more information, please visit our website at http://www.chinacordbloodcorp.com .

Safe Harbor Statement

This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events, performance and results of operations, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in statements filed from time to time with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

For more information, please contact: China Cord Blood Corporation Ms. Joeling Law Tel: +852-3605-8180 Email: ir@chinacordbloodcorp.com ICR, LLC In New York: Ashley M. Ammon or Christine Duan Tel: +1-646-277-1227 In Beijing: Wen Lei Zheng Tel: +86-10-6599-7968
'/>"/>

SOURCE China Cord Blood Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds Industrial Biotechnology China News 1009
2. According to Opurity, Feds Put U.S. Consumers at Risk: PTO Bureaucrats Refuse to Approve Vitamin Companys China-Free Trademark
3. Biopharma Leaders to Reveal Successful Strategies for China, India at the PharmAsia Summit in San Francisco
4. China Cord Blood Corporation Updates Status Regarding Share Repurchase Program
5. China Pharma Holdings, Inc. Successfully Completes Phase I Clinical Trials of New Anti-Drug-Resistance Antibiotic
6. China-Biotics Hosted its First Investor Day Event
7. Cord Blood America CEO Matthew Schissler Discusses Projects in China, South America, Afford-A-Cord, and Profitability
8. China Cord Blood Corporation to Launch Warrant Exchange Offer
9. China Cord Blood Corporation Reports First Quarter Fiscal 2011 Financial Results
10. China-Biotics Ranked Number 62 on FORTUNES 100 Fastest-Growing Companies List
11. Reportlinker Adds Advances in Biopharmaceutical Technology in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... ... February 04, 2016 , ... ... triple quad LC-MS, host live demos and poster sessions, and present on the ... The conference takes place March 6 to 10 at the Georgia World Congress ...
(Date:2/4/2016)... Feb. 4, 2016  CytoSorbents Corporation (NASDAQ: ... its flagship CytoSorb® blood filter to treat deadly ... the world, announced that CEO Dr. Phillip ... Source Capital Group,s 2016 Disruptive Growth & Healthcare ... company.  Conference Presentation Details: ...
(Date:2/4/2016)... , Feb. 4, 2016 ContraVir Pharmaceuticals, ... on the development and commercialization of targeted antiviral therapies, ... & Investor Conference 2016, to be held February 8-9, ... Capital Group,s 2016 Disruptive Growth & Healthcare Conference, taking ... February 10-11, 2016. James Sapirstein , Chief ...
(Date:2/4/2016)... Oakland, California (PRWEB) , ... February 04, 2016 ... ... Artificial Intelligence (AI) and leading supplier of Semantic Graph Database technology has been ... Graph Database Products ” by Corporate America Magazine. , “At Corporate America, it’s ...
Breaking Biology Technology:
(Date:1/21/2016)... --> ... report "Emotion Detection and Recognition Market by Technology (Bio-Sensors, NLP, ... Voice Recognition and Others), Services, Application Areas, End ... published by MarketsandMarkets, the global Emotion Detection and ... Billion by 2020, at a CAGR of 31.9%, ...
(Date:1/20/2016)... 2016   MedNet Solutions , an innovative SaaS-based ... clinical research, is pleased to announce the attainment of ... the result of the company,s laser focus on (and ... , it,s comprehensive, easy-to-use and highly affordable cloud-based technology ... Key MedNet growth achievements in 2015 include: ...
(Date:1/18/2016)... SAN JOSE, Calif. , Jan. 18, 2016 ... storage security software that simplifies the use and ... a technology and go-to-market partnership with American Cyber.  ... "American Cyber brings extensive experience leading transformational C4ISR ... missions implementing and integrating the latest proven technology ...
Breaking Biology News(10 mins):